Ceftazidime pharmacokinetics

Norrby SR, Burman LA, Linderholm H, Trollfors B. Ceftazidime pharmacokinetics in patients and effects on the renal function. J Antimicrob Chemother 1982 10(3) 199-206. [Pg.698]

Mouton, J., Vinks, A., and Punt, N., Pharmacokinetic-pharmacodynamic modeling of activity of ceftazidime during continuous and intermittent infusion, Antimicrobial Agents and Chemotherapy, Vol. 41, No. 4, 1997, pp. 733-738. [Pg.418]

Davies SP, Lacey LF, Kox WJ, Brown EA. Pharmacokinetics of cefuroxime and ceftazidime in patients with acute renal failure treated by continuous arteriovenous haemodialysis. Nephrol Dial Transplant 1991 6 971-6. [Pg.71]

Ohkawa M, Nakashima T, Shoda R, Ikeda A, Orito M, Sawaki M, Sugata T, Shimamura M, Hirano S, Oku-mura K. Pharmacokinetics of ceftazidime in patients with renal insufficiency and in those undergoing hemodialysis. Chemotherapy 1985 31 410-6. [Pg.71]

Meredith TA. Antimicrobial pharmacokinetics in endophthalmitis treatment studies of ceftazidime. Trans Am Ophth Soc 1993 91 653-699. [Pg.95]

Kalman, D. Barriere, S.L. Johnson, B.L., Jr. Pharmacokinetic disposition and bactericidal activities of cefepime, ceftazidime, and cefoperazone in serum and blister fluid. Antimicrob.Agents Chemother., 1992, 36, 453-457... [Pg.292]

Paradis, D. Vall4e, F. Allard, S. Bisson, C. Daviau, N. Drapeau, C. Auger, F. LeBel, M. Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem, and ciprofloxacin. Aretimicro6.Agerafs Chemother., 1992, 36, 2085-2092... [Pg.297]

Kinowski, J.M. Bressolle, F. Fabre, D. Goncalves, F. Rouzier-Panis, R. Galtier, M. High-performance liquid chromatographic determination of ceftibuten and its metabolite in biological fluids Application in pharmacokinetic studies. J.Pharm.Sci., 1994, 83, 736—741 [plasma extracted ceftibuten ceftazidime is IS]... [Pg.302]

Vinks, A.A.T.M.M. Touw, D.J. Heijerman, H.G.M. Danhof, M. de Leede, G.P.J. Bakker, W. Pharmacokinetics of ceftazidime in adult cystic fibrosis patients during continuous infusion and ambulatory treatment at home. Ther.Drug Monit., 1994,16, 341-348 [pharmacokinetics serum urine sputum LOD 500 ng/mL 8-chlorotheophylline (IS)]... [Pg.302]

Guiso, G. Rambaldi, A. Dimitrova, B. Biondi, A. Caccia, S. Determination of orally administered all-trans-retinoic acid in human plasma by high-performemce liquid chromatography. J.Chromatogr.B, 1994, 656, 239—244 [all-trans-retinyl acetate (IS) extracted metabolites, isotretinoin, tretinoin LOD 10 ng/mL pharmacokinetics non-interfering allopurinol, amikacin, aracytin, ceftazidime, ciprofloxacin, doxorubicin, fluconazole, prednisone]... [Pg.1232]

Adamis G, Papaioannou MG, Giamarellos-Bourboulis EJ, Gargalianos P, Kosmidis J, Gia-marellouH, Pharmacokinetic interactions of ceftazidime, imipenem andaztreonam witii amikacin in healthy volunteers, IntJAntimicrob Agents (2004) 23,144-9,... [Pg.287]

Ceftazidime Intravenous Probenecid 500 mg every 6 hours for 24 hours before and 1 g immediately before a single intravenous dose of ceftazidime 1 g did not significantly affect ceftazidime clearance. Pharmacokinetics of single 50-mg/l dose of ceftazidime in patients with cystic fibrosis not affected by pre-treatment with probenecid 2 g 19,26... [Pg.297]

Luthy R, Blaser J, Bonetti A, Simmen H, Wise R, Siegenthaler W. Comparative multiple-dose pharmacokinetics of cefotaxime, mo mlactam, and ceftazidime. Antimicrob Agents Chemotiier 1981) 20, 567-75. [Pg.298]

Kercsmar CM, Stem RC, Reed MD, Myers CM, Murdell D, Blumer JL. Ceftazidime in c tic fibrosis pharmacokinetics and therapeutic respwise. J Antimicrob Chemother (1983) 12 (Suppl.A) 289-95. [Pg.298]

A study found that a single 2-g intravenous dose of ceftazidime had no effect on the pharmacokinetics of pefloxacin, and pefloxacin did not affect the pharmacokinetics of ceftazidime. ... [Pg.339]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...